Articles

Fracturing U.S. relations around the world are making inflation near 3% likely, BlackRock says

Investment giant BlackRock Inc. is making what it calls one of its strongest strategic calls of the moment: Inflation that's likely to stay closer to 3% as the world increasingly splits itself into competing blocs.

The latest from the ‘Single Greatest Predictor of Future Stock Market Returns’

A sobering story about the stock market’s long-term future return

Here’s how much caffeine is in Panera’s Charged Lemonade, Starbucks coffee, Celsius and other popular drinks

Jittery about how much caffeine you sip, in light of the third lawsuit against Panera’s Charged Lemonade? This chart shows the caffeine content of some popular drinks.

Here’s a new way to consider value for stocks in the S&P 500

A look back at quality highlights companies that have made a lot of money for investors and are expected to grow earnings rapidly through 2025.

Goldman Sachs leads Dow Jones Industrial Average in rally

Investment bank's 2% gain boosts rise 157-point rise from DJIA.

U.S. IPO market awaits another $1 billion week, with BrightSpring on tap

The IPO market is coming back to life, with a second week of at least $1 billion worth of deals on tap.

SPAC buying Trump’s Truth Social has nearly doubled over six-session win streak

DWAC's stock was also on track for its longest winning streak since the six-day period ending March 4, 2022.

I want my father to quitclaim his home so I can refinance it — and take out a $200,000 annuity for my sister and me. Is this wise?

“Last April, my sister racked up $20,000 on our father’s credit cards, and tried to take upwards of $13,000 from his bank account.”

Apple Vision Pro may have sold out, but one analyst has a ‘major concern’

An analyst is concerned that Vision Pro delivery times didn't continue to increase after the device sold out initially.

ICICI Bank’s stock rallies toward a record as decline in net interest margin is seen ‘nearing its end’

ICICI Bank's U.S.-listed stock rallied into record territory Monday, as investors cheered the India-based bank's fiscal third-quarter results, which showed that the compression in net interest margin was nearing its end.

Leading indicators fall again, but U.S. appears no closer to recession

Leading economic index dips 0.1% in December

Gilead’s stock tumbles toward biggest selloff in more than nine years as lung-cancer trial disappoints

Shares of Gilead Sciences tumbled 9.7% early Monday after the company reported disappointing lung-cancer trial results.
1 1,647 1,648 1,649 1,650 1,651 2,412